Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Joshua Kennedy

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
22
2025
317
6.080
Why?
Picornaviridae Infections
11
2025
22
3.750
Why?
Rhinovirus
14
2025
24
3.480
Why?
Virus Diseases
4
2024
46
2.530
Why?
Rhinitis
5
2018
28
2.350
Why?
Sinusitis
5
2018
42
2.290
Why?
Desensitization, Immunologic
5
2018
107
1.920
Why?
Respiratory Tract Infections
4
2025
82
1.880
Why?
Hypersensitivity
6
2022
81
1.580
Why?
Rural Population
2
2025
572
1.320
Why?
Lung
4
2024
501
1.230
Why?
Drug Hypersensitivity
3
2018
39
1.170
Why?
Respiratory Sounds
6
2025
50
1.080
Why?
Respiratory Hypersensitivity
4
2020
17
1.040
Why?
Disaccharides
2
2015
11
0.900
Why?
Immunoglobulin E
8
2020
92
0.890
Why?
Urticaria
2
2015
19
0.890
Why?
Rhinitis, Allergic, Perennial
2
2014
4
0.880
Why?
Humans
51
2025
52593
0.880
Why?
Androstadienes
2
2014
11
0.880
Why?
Meat
2
2015
60
0.880
Why?
Rhinitis, Allergic, Seasonal
2
2014
8
0.880
Why?
Coinfection
1
2024
44
0.840
Why?
Viruses
1
2023
24
0.820
Why?
Pharyngitis
1
2022
19
0.790
Why?
Health Promotion
1
2025
268
0.770
Why?
Carbachol
3
2020
26
0.770
Why?
Streptococcal Infections
1
2022
49
0.760
Why?
Hospitalization
2
2024
749
0.710
Why?
Allergens
6
2019
141
0.650
Why?
Eosinophils
3
2017
44
0.640
Why?
Child
14
2024
7229
0.630
Why?
Th2 Cells
2
2016
23
0.630
Why?
Bronchoconstriction
1
2019
6
0.620
Why?
Anaphylaxis
2
2018
69
0.610
Why?
Aspirin
2
2017
123
0.600
Why?
Bronchodilator Agents
2
2019
77
0.580
Why?
Mesalamine
1
2017
12
0.540
Why?
Adolescent
14
2025
6737
0.530
Why?
Ketorolac
1
2016
2
0.530
Why?
Itraconazole
1
2016
38
0.520
Why?
Staphylococcus
2
2013
32
0.510
Why?
Viral Load
3
2022
80
0.510
Why?
Food Hypersensitivity
2
2019
100
0.510
Why?
Colitis, Ulcerative
1
2017
67
0.510
Why?
Acetaminophen
1
2019
279
0.500
Why?
Immunologic Factors
1
2016
117
0.490
Why?
Male
21
2025
26863
0.470
Why?
Arkansas
7
2024
2029
0.470
Why?
Child, Preschool
8
2024
4062
0.440
Why?
Candidiasis
1
2014
113
0.420
Why?
Female
20
2025
28262
0.420
Why?
Allergy and Immunology
1
2013
19
0.420
Why?
Hypersensitivity, Delayed
1
2013
18
0.410
Why?
Manikins
1
2013
35
0.410
Why?
Lymphangitis
1
2013
2
0.410
Why?
Emergency Medicine
1
2013
51
0.410
Why?
Bronchi
1
2012
43
0.390
Why?
Pruritus
1
2013
45
0.390
Why?
Eosinophilia
1
2013
36
0.390
Why?
Common Cold
1
2012
5
0.390
Why?
Edema
1
2013
66
0.390
Why?
Animals
12
2024
13507
0.370
Why?
Chronic Disease
4
2016
588
0.370
Why?
Enterovirus Infections
2
2022
7
0.360
Why?
Adult
13
2025
14170
0.350
Why?
Eosinophilic Esophagitis
2
2024
43
0.350
Why?
Esophagus
2
2024
83
0.350
Why?
Pediatrics
1
2013
295
0.330
Why?
Staphylococcal Infections
1
2013
280
0.330
Why?
Emergency Service, Hospital
2
2024
524
0.310
Why?
Cytokines
3
2024
626
0.310
Why?
Interferons
2
2022
37
0.300
Why?
Diagnosis, Differential
3
2018
1048
0.300
Why?
Anti-Allergic Agents
2
2020
16
0.300
Why?
Pandemics
2
2024
587
0.290
Why?
Middle Aged
7
2025
13096
0.280
Why?
Anti-Bacterial Agents
1
2013
803
0.280
Why?
Age Factors
3
2024
1132
0.280
Why?
Bacteria
2
2023
220
0.280
Why?
Immunity, Innate
3
2024
117
0.270
Why?
Myocytes, Smooth Muscle
2
2025
96
0.260
Why?
Young Adult
6
2023
4337
0.260
Why?
Disease Progression
3
2020
873
0.240
Why?
Arachidonate 5-Lipoxygenase
1
2025
3
0.240
Why?
GATA3 Transcription Factor
1
2025
7
0.240
Why?
Respiratory Syncytial Virus Infections
1
2025
39
0.240
Why?
Alaska
1
2025
24
0.230
Why?
Interleukins
2
2015
34
0.220
Why?
Influenza, Human
1
2025
85
0.220
Why?
Cells, Cultured
4
2025
1588
0.220
Why?
Mycoplasma pneumoniae
1
2024
5
0.220
Why?
Regeneration
1
2024
79
0.220
Why?
Skin Tests
2
2013
58
0.200
Why?
Swine
2
2015
427
0.200
Why?
Virus Replication
1
2024
150
0.200
Why?
Streptococcus pyogenes
1
2022
18
0.200
Why?
Antiviral Agents
1
2024
177
0.200
Why?
Fibroblasts
1
2024
359
0.200
Why?
Students
1
2023
228
0.170
Why?
Autoantibodies
1
2021
121
0.170
Why?
Infant
3
2024
3720
0.170
Why?
Enterovirus
1
2020
8
0.170
Why?
Muscle, Smooth
1
2020
64
0.160
Why?
Calcium Signaling
1
2020
52
0.160
Why?
Respiratory System
1
2020
28
0.160
Why?
Organ Culture Techniques
1
2019
44
0.150
Why?
Cell Differentiation
2
2024
673
0.150
Why?
Disease Susceptibility
1
2019
96
0.150
Why?
Mice, Inbred Strains
1
2019
164
0.150
Why?
Seroepidemiologic Studies
3
2023
44
0.150
Why?
Nasal Polyps
1
2018
4
0.150
Why?
Acetazolamide
1
2018
17
0.150
Why?
Treatment Outcome
5
2018
5486
0.150
Why?
Pseudotumor Cerebri
1
2018
25
0.140
Why?
Albuterol
1
2019
57
0.140
Why?
RNA, Viral
2
2020
125
0.140
Why?
Antibodies, Viral
3
2023
110
0.140
Why?
Food Supply
1
2019
92
0.140
Why?
Host-Pathogen Interactions
1
2019
144
0.140
Why?
Risk Factors
2
2024
3952
0.140
Why?
Parainfluenza Virus 3, Human
1
2017
5
0.140
Why?
Respirovirus Infections
1
2017
6
0.140
Why?
Immunization
2
2017
68
0.130
Why?
Prevalence
2
2019
1017
0.130
Why?
Infant, Newborn
1
2024
2891
0.130
Why?
Th1-Th2 Balance
1
2016
2
0.130
Why?
Health Literacy
1
2019
132
0.130
Why?
Cross-Sectional Studies
3
2022
1686
0.130
Why?
Anticonvulsants
1
2018
134
0.130
Why?
Leukotrienes
1
2016
9
0.130
Why?
Immunocompromised Host
1
2017
123
0.130
Why?
Lymphocyte Activation
1
2016
163
0.130
Why?
Genetic Predisposition to Disease
1
2019
528
0.120
Why?
High-Throughput Nucleotide Sequencing
1
2017
179
0.120
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
124
0.120
Why?
Dose-Response Relationship, Drug
1
2019
1378
0.120
Why?
Intracellular Membranes
1
1995
22
0.120
Why?
Interleukin-17
1
2015
35
0.110
Why?
Basophils
1
2014
14
0.110
Why?
Candidiasis, Chronic Mucocutaneous
1
2014
2
0.110
Why?
Myoglobin
1
1995
25
0.110
Why?
Thymoma
1
2014
11
0.110
Why?
Eosinophil Cationic Protein
1
2014
1
0.110
Why?
Nasal Lavage Fluid
1
2014
2
0.110
Why?
Candida
1
2014
63
0.110
Why?
Oxidative Stress
1
2019
810
0.110
Why?
Decision Making, Computer-Assisted
1
2014
4
0.110
Why?
Leukocyte Count
1
2014
73
0.110
Why?
Intercellular Adhesion Molecule-1
1
2014
59
0.110
Why?
Administration, Intranasal
1
2014
31
0.110
Why?
Superantigens
1
2013
1
0.110
Why?
Markov Chains
1
2014
30
0.110
Why?
Emergency Treatment
1
2013
29
0.110
Why?
Nasal Mucosa
1
2013
19
0.110
Why?
Preoperative Period
1
2013
47
0.100
Why?
Case-Control Studies
2
2014
1202
0.100
Why?
Decision Support Techniques
1
2014
71
0.100
Why?
Virginia
1
2013
19
0.100
Why?
Mice, Inbred C57BL
1
2019
1900
0.100
Why?
Paranasal Sinuses
1
2013
15
0.100
Why?
Antibodies, Anti-Idiotypic
1
2013
25
0.100
Why?
Cats
1
2013
73
0.100
Why?
Angioedema
1
2013
11
0.100
Why?
Cough
1
2013
56
0.100
Why?
Postoperative Period
1
2013
172
0.100
Why?
Affect
1
2013
104
0.100
Why?
Sex Distribution
1
2013
138
0.100
Why?
Dogs
1
2013
183
0.100
Why?
Acute Disease
1
2014
387
0.100
Why?
Age Distribution
1
2013
175
0.100
Why?
Statistics, Nonparametric
1
2013
196
0.100
Why?
Polymerase Chain Reaction
1
2014
460
0.100
Why?
Cattle
1
2013
207
0.100
Why?
Cost-Benefit Analysis
1
2014
269
0.100
Why?
Equipment Design
1
2013
288
0.100
Why?
Pyroglyphidae
1
2012
1
0.100
Why?
Oxygen
1
1995
336
0.100
Why?
Odds Ratio
1
2014
568
0.100
Why?
Myocardium
1
1995
479
0.090
Why?
Biofilms
1
2013
190
0.090
Why?
Virulence
1
2012
167
0.090
Why?
Patient Care Team
1
2013
273
0.090
Why?
Prospective Studies
2
2017
2457
0.090
Why?
Chemokine CXCL10
2
2022
20
0.090
Why?
Logistic Models
1
2014
934
0.090
Why?
Antibodies, Monoclonal, Humanized
1
2013
237
0.090
Why?
Clinical Competence
1
2013
404
0.080
Why?
Incidence
1
2013
1077
0.080
Why?
Time Factors
2
2013
3000
0.080
Why?
Tomography, X-Ray Computed
1
2014
1162
0.080
Why?
Cohort Studies
1
2013
1553
0.070
Why?
Risk Assessment
1
2013
1350
0.070
Why?
Genome, Viral
2
2020
83
0.070
Why?
Longitudinal Studies
2
2023
747
0.070
Why?
Prognosis
1
2013
2118
0.070
Why?
United States
1
2016
5227
0.060
Why?
Respiratory Function Tests
2
2020
90
0.060
Why?
Cell Movement
1
2024
276
0.050
Why?
Interleukin-15
1
2022
15
0.050
Why?
Serologic Tests
1
2022
25
0.050
Why?
Multiple Myeloma
1
2017
3050
0.050
Why?
Epidermal Growth Factor
1
2022
37
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2022
64
0.050
Why?
Universities
1
2023
175
0.050
Why?
Interleukin-8
1
2022
86
0.050
Why?
Cluster Analysis
1
2022
233
0.050
Why?
Peptidyl-Dipeptidase A
1
2021
27
0.050
Why?
RNA, Messenger
1
2025
1139
0.050
Why?
Receptor, Angiotensin, Type 1
1
2021
56
0.040
Why?
Renin-Angiotensin System
1
2021
58
0.040
Why?
Cell Proliferation
1
2025
1029
0.040
Why?
Interleukin-6
1
2022
277
0.040
Why?
Angiotensin II
1
2021
162
0.040
Why?
Myosin Light Chains
1
2020
4
0.040
Why?
Placebo Effect
1
2020
16
0.040
Why?
Histamine
1
2020
25
0.040
Why?
Primary Prevention
1
2020
44
0.040
Why?
Inflammation Mediators
1
2020
116
0.040
Why?
Muscle Contraction
1
2020
116
0.040
Why?
Tertiary Healthcare
1
2019
15
0.040
Why?
Protein Processing, Post-Translational
1
2020
153
0.040
Why?
Phosphorylation
1
2020
530
0.040
Why?
Hypersensitivity, Immediate
1
2018
15
0.040
Why?
Coculture Techniques
1
2018
145
0.040
Why?
Immune Tolerance
1
2018
91
0.040
Why?
Double-Blind Method
1
2020
718
0.040
Why?
Air Pollutants
1
2018
75
0.040
Why?
Particulate Matter
1
2017
63
0.030
Why?
Seasons
1
2017
91
0.030
Why?
Proton Pump Inhibitors
1
2017
86
0.030
Why?
Cross Infection
1
2017
93
0.030
Why?
Environmental Exposure
1
2017
216
0.030
Why?
Partial Pressure
1
1995
14
0.030
Why?
Phosphorus
1
1995
29
0.030
Why?
Receptors, Cytokine
1
2014
11
0.030
Why?
Protons
1
1995
71
0.030
Why?
Magnetic Resonance Spectroscopy
1
1995
253
0.030
Why?
Protein-Tyrosine Kinases
1
2014
89
0.030
Why?
Adenosine Triphosphate
1
1995
209
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2014
137
0.030
Why?
Quality of Life
1
2019
882
0.030
Why?
Exhalation
1
2012
21
0.020
Why?
Epitopes
1
2012
62
0.020
Why?
Rats, Sprague-Dawley
1
1995
1554
0.020
Why?
Risk
1
2012
313
0.020
Why?
Nitric Oxide
1
2012
244
0.020
Why?
Rats
1
1995
3203
0.020
Why?
Spirometry
1
2008
33
0.020
Why?
Respiratory Therapy
1
2008
36
0.020
Why?
Adrenal Cortex Hormones
1
2008
114
0.020
Why?
Administration, Oral
1
2008
455
0.020
Why?
Practice Guidelines as Topic
1
2008
496
0.010
Why?
Severity of Illness Index
1
2008
1037
0.010
Why?
Retrospective Studies
1
2017
6671
0.010
Why?
Follow-Up Studies
1
2008
2291
0.010
Why?
Kennedy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description